How long does hydrochlorothiazide stay in your system

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Duration of Hydrochlorothiazide in the System

Absorption and Metabolism of Hydrochlorothiazide

Hydrochlorothiazide (HCT) is a commonly used diuretic for treating hypertension. When administered orally, it is absorbed primarily in the duodenum and upper jejunum, with an absorption rate ranging between 60% and 80% . The drug is not significantly metabolized in the body, as more than 95% of the absorbed or injected HCT is excreted unchanged in the urine .

Excretion and Half-Life

The excretion of HCT is predominantly through the urine, with no significant biliary excretion observed . In studies involving both healthy subjects and hypertensive patients, the plasma levels of HCT decline in a biphasic manner. The initial fast phase has a half-life of approximately 1.7 hours, while the slower phase has a half-life of about 13.1 hours . This biphasic decline indicates that HCT remains in the system for a considerable duration, with the slower phase contributing to its prolonged presence in the body.

Accumulation in Blood Cells

HCT tends to accumulate in blood cells, with the ratio of radioactivity in cells to that in plasma averaging 3.5 . This accumulation can influence the overall duration HCT stays in the system, as it may be slowly released from the cells back into the plasma over time.

Excretion in Animal Studies

In animal studies, specifically in saline-loaded, fasted rats, HCT was rapidly absorbed and a significant portion of the drug was excreted in the urine within 48 hours. Depending on the dosage, between 43% and 69% of the administered HCT was excreted during this period . These findings support the notion that HCT is efficiently eliminated through renal pathways.

Conclusion

Hydrochlorothiazide is absorbed quickly and primarily excreted unchanged in the urine. It exhibits a biphasic elimination pattern with a fast phase half-life of 1.7 hours and a slow phase half-life of 13.1 hours, indicating that it can stay in the system for an extended period. The drug also accumulates in blood cells, which may further prolong its presence in the body. Overall, HCT is efficiently eliminated through renal excretion, with significant amounts being excreted within 48 hours.

Sources and full results

Most relevant research papers on this topic

Absorption, metabolism, and excretion of hydrochlorothiazide

Hydrochlorothiazide is mainly eliminated in the urine, with a slow phase after oral administration and a fast phase after iv administration.

Non-RCTHighly Cited

1976·

166citations

·B. Beermann et al.

Clinical Pharmacology & Therapeutics·

DOI

Distribution and fate of hydrochlorothiazide-H3.

Hydrochlorothiazide-H3 is rapidly absorbed and rapidly excreted into the urine in fasted rats, with no evidence of metabolic alteration.

Non-RCTAnimal Study

1960·

16citations

·H. Sheppard et al.

Toxicology and applied pharmacology·

DOI

A controlled multiclinic study to compare the antihypertensive effects of MK-421, hydrochlorothiazide, and MK-421 combined with hydrochlorothiazide in patients with mild to moderate essential hypertension.

Enalapril and enalapril/hydrochlorothiazide effectively treat mild to moderate essential hypertension, with similar frequency of adverse effects and rare serious side effects.

1984·

36citations

·Vidt Dg

Journal of Hypertension

The effect of chronic hydrochlorothiazide administration on renal function in the rat.

Chronic hydrochlorothiazide administration in rats leads to increased sodium reabsorption in the proximal tubules, reducing sodium delivery to the nephron site and reducing fluid delivery.

Non-RCTAnimal Study

1986·

42citations

·S. Walter et al.

Clinical science·

DOI

Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring.

Low-dose chlorthalidone, 6.25 mg daily, effectively reduces 24-hour blood pressure in patients with essential hypertension, while low-dose hydrochlorothiazide monotherapy is not appropriate due to its short duration of action.

RCTVery Rigorous JournalHighly Cited

2016·

75citations

·A. Pareek et al.

Journal of the American College of Cardiology·

DOI

Comparative Antihypertensive Effects of Hydrochlorothiazide and Chlorthalidone on Ambulatory and Office Blood Pressure

Chlorthalidone is more effective in lowering systolic blood pressure than hydrochlorothiazide at recommended doses, but these differences are not apparent with office blood pressure measurements.

RCTHighly Cited

2006·

425citations

·M. Ernst et al.

Hypertension·

DOI

Clinical observations on the diuretic effect of hydrochlorothiazide.

Hydrochlorothiazide is effective in reducing fluid retention in congestive heart failure patients, with most patients receiving 100 to 150 mg. per day in divided doses.

Observational Study

1961·

3citations

·G. Czoniczer et al.

The American journal of cardiology·

DOI

Hydrochlorothiazide effects on serum calcim and immunoreactive parathyroid hormone concentrations. Studies in normal subjects.

Hydrochlorothiazide increases serum calcium levels without significantly affecting protein binding or iPTH levels, but the normal negative correlation between ionized calcium and iPTH remains intact.

Non-RCTHighly Cited

1972·

85citations

·R. Stote et al.

Annals of internal medicine·

DOI

Hydrochlorothiazide in the treatment of hypertension. The effects on blood volume, exchangeable sodium and blood pressure.

Hydrochlorothiazide effectively lowers blood pressure and exchangeable sodium in essential hypertension patients, suggesting hypovolemia may explain its antipressor effect even after three months of treatment.

2009·

42citations

·J. Hansen

Acta medica Scandinavica·

DOI

Bioavailability and disposition of metoprolol and hydrochlorothiazide combined in one tablet and of separate doses of hydrochlorothiazide.

Metoprolol and hydrochlorothiazide combined in a tablet do not significantly influence each other's bioavailability or time-course, making repeated doses unlikely to cause significant clinical interactions.

Non-RCT

1979·

25citations

·L. Jordö et al.

British journal of clinical pharmacology·

DOI

Try another search

elliptical orbits

solar meaning

regulation of expression

how long gastritis heal

which activity is an example of biotechnology

what's mitigation